Low-dose hCG supplementation after GnRH agonist triggering: Don't be too quick on the trigger

Human Reproduction

Volumn 28, Issue 9, 2013, Pages 2315-2317

  Bodri, Daniel ^a  

^a Fertility Center Mallorca   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN AGONIST;

EMBRYO TRANSFER; FREEZING; HIGH RISK PATIENT; HUMAN; LUTEAL PHASE; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; PREGNANCY OUTCOME; REVIEW;

CHORIONIC GONADOTROPIN; EMBRYO TRANSFER; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; IN VITRO OOCYTE MATURATION TECHNIQUES; OOCYTES; OVARIAN HYPERSTIMULATION SYNDROME; RISK; TIME FACTORS;

EID: 84883205240     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/det125     Document Type: Review

References (16)

1. Bodri D, Guillen JJ, Trullenque M, Schwerin K, Esteve C, Coll O. Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study. Fertil Steril 2010;93:2418-2420.
2. Castillo JC, Dolz M, Bienvenido E, Abad L, Casan EM, Bonilla-Musoles F. Cycles triggered with GnRH agonist: exploring low-dose HCG for luteal support. Reprod Biomed Online 2010;20:175-181.
3. Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril 2008;89:84-91.
4. Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a 'freeze-all' strategy: a prospective multicentric study. Fertil Steril 2011 95:2029-2033, 2033 e2021.
5. Humaidan P. Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low dose HCG: a pilot study. Reprod Biomed Online 2009; 18:630-634.
6. Humaidan P, Bungum L, Bungum M, Yding Andersen C. Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod Biomed Online 2006; 13:173-178. (Pubitemid 44207763)
7. Humaidan P, Ejdrup Bredkjaer H, Westergaard LG, Yding Andersen C. 1500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fert/7 Steril 2010;93:847-854.
8. Humaidan P, Kol S, Papanikolaou EG, Copenhagen Gn RHATWG. GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update 2011; 17:510-524.
9. Kol S. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril 2004; 81:1-5. (Pubitemid 38058315)
10. Kol S, Humaidan P. GnRH agonist triggering: recent developments. Reprod Biomed Online 2013;26:226-230.
11. Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, Van Steirteghem A, Devroey P. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril 2006; 85:112-120. (Pubitemid 43063432)
12. Papanikolaou EG, Humaidan P, Polyzos N, Kalantaridou S, Kol S, Benadiva C, Tournaye H, Tarlatzis B. New algorithm for OHSS prevention. Reprod Biol Endocrinol 201 1a;9:147.
13. Papanikolaou EG, Verpoest W, Fatemi H, Tarlatzis B, Devroey PTournaye H. A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study. Fertil Steril 2011b; 95:1174-1177.
14. Radesic B, Tremellen K. Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates. Hum Reprod 2011;26:3437-3442.
15. Seyhan A, Ata B, Polat M, Son W-Y, Yarali H, Dahan MH. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1, 500IU h CG. Hum Reprod 2013;28:2522-2528.
16. van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M. Luteal phase support forassisted reproduction cycles. Cochrane Database Syst Rev 2011;CD009154.